vos-headline-type-email-header-062620
feature art_article_344x414
Featured

Addressing Assessment and Access Issues for Rare Diseases

With the promise of more rare disease treatments on the horizon (particularly genetic treatments for hemophilia and sickle cell disease, which promise to be “one and done” therapies), their much higher per patient cost will create market access and other challenges to payers, providers, and patients.

ISSUE HIGHLIGHTS

COLUMNS

vos_heorarticles_100x100
HEOR Articles
The Role of Education in Shaping an Open-Source Future
vos_bythenumbers_100x100
By the Numbers
HEOR & Rare Diseases
vos_fromthejournals_100x100
From the Journals
A Data-Driven Approach to Support the Understanding and Improvement of Patients’ Journeys: A Case Study Using Electronic Health Records of an Emergency Department
vos_researchroundup_100x100
Research Roundup
Research Roundup
vos_heornews_100x100
HEOR News
HEOR News
vos_conferences_100x100
ISPOR Conferences
ISPOR Conferences and Events
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×